Marathon Partners Equity Management LLC Invests $6.06 Million in Henry Schein, Inc. (NASDAQ:HSIC)

Marathon Partners Equity Management LLC purchased a new stake in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 87,500 shares of the company's stock, valued at approximately $6,055,000. Henry Schein accounts for approximately 5.3% of Marathon Partners Equity Management LLC's portfolio, making the stock its 6th largest position. Marathon Partners Equity Management LLC owned 0.07% of Henry Schein at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of the business. Smartleaf Asset Management LLC lifted its position in Henry Schein by 23.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 759 shares of the company's stock valued at $52,000 after acquiring an additional 143 shares during the period. Guggenheim Capital LLC lifted its position in Henry Schein by 2.5% during the 4th quarter. Guggenheim Capital LLC now owns 6,428 shares of the company's stock valued at $445,000 after acquiring an additional 159 shares during the period. CIBC Asset Management Inc lifted its position in Henry Schein by 1.0% during the 4th quarter. CIBC Asset Management Inc now owns 17,849 shares of the company's stock valued at $1,235,000 after acquiring an additional 169 shares during the period. Metis Global Partners LLC lifted its position in Henry Schein by 4.7% during the 4th quarter. Metis Global Partners LLC now owns 4,203 shares of the company's stock valued at $291,000 after acquiring an additional 187 shares during the period. Finally, Sanctuary Advisors LLC lifted its position in Henry Schein by 5.0% during the 4th quarter. Sanctuary Advisors LLC now owns 4,253 shares of the company's stock valued at $294,000 after acquiring an additional 203 shares during the period. 96.62% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

HSIC has been the subject of several recent analyst reports. StockNews.com cut shares of Henry Schein from a "buy" rating to a "hold" rating in a report on Thursday, April 17th. Barrington Research decreased their target price on shares of Henry Schein from $90.00 to $86.00 and set an "outperform" rating for the company in a report on Tuesday, May 6th. Wells Fargo & Company decreased their target price on shares of Henry Schein from $80.00 to $75.00 and set an "equal weight" rating for the company in a report on Tuesday, May 6th. UBS Group decreased their target price on shares of Henry Schein from $83.00 to $80.00 and set a "neutral" rating for the company in a report on Wednesday, February 26th. Finally, Jefferies Financial Group lifted their target price on shares of Henry Schein from $77.00 to $80.00 and gave the stock a "hold" rating in a report on Thursday, January 23rd. Six research analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, Henry Schein has an average rating of "Moderate Buy" and a consensus target price of $79.30.

Insider Activity at Henry Schein

In related news, Director Philip A. Laskawy sold 2,604 shares of the business's stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total transaction of $184,988.16. Following the completion of the sale, the director now directly owns 24,805 shares in the company, valued at approximately $1,762,147.20. The trade was a 9.50% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Bradford C. Connett sold 4,036 shares of the business's stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total transaction of $287,161.40. Following the sale, the chief executive officer now owns 62,688 shares of the company's stock, valued at $4,460,251.20. This trade represents a 6.05% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.08% of the stock is currently owned by company insiders.

Henry Schein Stock Performance

Shares of HSIC stock traded up $0.51 during trading hours on Friday, reaching $72.05. The company had a trading volume of 1,036,158 shares, compared to its average volume of 1,645,302. The business has a fifty day moving average price of $67.34 and a 200-day moving average price of $71.46. Henry Schein, Inc. has a one year low of $60.56 and a one year high of $82.49. The firm has a market cap of $8.77 billion, a PE ratio of 29.65, a price-to-earnings-growth ratio of 2.13 and a beta of 0.87. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its quarterly earnings results on Monday, May 5th. The company reported $1.15 EPS for the quarter, topping analysts' consensus estimates of $1.11 by $0.04. The firm had revenue of $3.17 billion during the quarter, compared to analyst estimates of $3.24 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business's revenue for the quarter was down .1% on a year-over-year basis. During the same period in the previous year, the business posted $1.10 earnings per share. Sell-side analysts predict that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.